KRT17 as a prognostic biomarker for stage II colorectal cancer.
Ujiie D, Okayama H, Saito K, Ashizawa M, Thar Min AK, Endo E, Kase K, Yamada L, Kikuchi T, Hanayama H, Fujita S, Sakamoto W, Endo H, Saito M, Mimura K, Saze Z, Momma T, Ohki S, Kono K.
Ujiie D, et al. Among authors: hanayama h.
Carcinogenesis. 2020 Jul 10;41(5):591-599. doi: 10.1093/carcin/bgz192.
Carcinogenesis. 2020.
PMID: 31754689